NON-INVASIVE MONITORING OF EGFR MUTATIONS IN NONSMALL CELL LUNG CANCER (NSCLC) DURING TARGETED THERAPY: STATE OF THE ART AND OUR EXPERIENCE. Voprosy onkologii, v. 62, n. 4, p. 513–518, 15 Dec.2016.